drugset / Trial / NCT00515905
One-lung Ventilation: Expression of Pulmonary Inflammatory Mediators
RandomizedParallel-groupOpen-labelPrevention
Summary
One-lung ventilation; organ protection; volatile anesthetics One-lung ventilation has become a common procedure for thoracoscopic surgery. Two hypothesis will be tested in this study: 1. Are inflammatory mediators increased in the re-ventilated lung after short-period pulmonary collapse? 2. Does Sevoflurane influence the production of inflammatory mediators in the re-inflated lung? Therefore, this study will elucidate the potential protective effect of a volatile anaesthetic (sevoflurane) on the production of inflammatory mediators by the respiratory compartment of the lung, i.e. the alveolar epithelium. * Trial with immunomodulatory product / biological
Timeline
- Start
- 2004-10
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sevoflurane | Other / unclassified | — | — |
| Background | Propofol | Small molecule | — | — |
Indications
No indication recorded.